Roche announces that its Tina-quant lipoprotein Lp RxDx test has been designated a breakthrough device by the U.S. FDA to identify patients likely to benefit from an innovative Lp-lowering therapy.
Roche obesity therapy causes ~19% weight loss (OTCQX:RHHBY) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.